Study: Amyloid imaging shows promise in AD diagnosis, treatment

01/12/2010 | Medical News Today

Researchers who reviewed results of previous studies that used PET scans with the Pittsburgh Compound-B tracer to image amyloid-beta plaques in the brains of older subjects said the tracer identified plaque deposits in a significant number of cognitively normal subjects and found that the deposits are linked to brain atrophy even in those without cognitive symptoms. The researchers predict that in the future, clinicians will be able to use amyloid imaging as a tool to determine the patients with mild or atypical symptoms and those who might need treatments.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ